Test Run and Web Checks

Pre-forum Workshop: Portfolio Enhancement & Product Rationalization (Dr Avijit Kelkar, Co-Founder, Aharav Consultants, UK)

Welcome Address and Introduction to Experts and Expert Forum
Sanjay Bajaj, CEO & MD, Glostem Private Limited, India

Pharmacological & Clinical Aspects in Drug Repurposing
Ambrish Srivastava, Clinical Consultant, Evolve Life Research, India

The Myths of Repurposing Drugs
Ken V Phelps, President & Founder, Camargo Pharmaceutical Services, USA

Drug Repurposing in Oncology - From Candidate Selection to Clinical Investigation
Pan Pantziarka, Programme Director - Drug Repurposing, Anticancer Fund, United Kingdom

Open Discussion/Rap Session: (Experts - Purushottam Dewang and Pratima Srivastava)

Regulatory Pathways for Repurposed Drugs and 505(B)2 Hurdles
Asoke Mukherjee, Former - Senior Expert Pharmacologist, FDA, USA

Reverse Pharmacology and Systems Approaches for Chemical Biology, Drug Discovery and Development: Inspiration from the Wisdom of Mother Nature
Mukund Chorghade, President and Chief Scientific Officer, THINQ Pharma, USA

End of First Day of meeting

Recap of Day 1 and Introduction to Day 2 Experts
Sanjay Bajaj, CEO & MD, Glostem Private Limited, India

Repositioning of Existing Drugs through Novel Product Development Approaches
Rakesh Bhasin, Vice President - Gen-Form, Biocon Limited, India

Open Discussion - Formulation Development Approaches (Lead Experts - Manish Grover and Wantanee Phuapradit)

Drug Repurposing using In Silico and 3D Human Vascular Lung Models: A Case Example for Covid Antiviral Clinical Candidate Selection

Overview of Drug Repurposing for Covid Antiviral Clinical Candidate
Subrahmanyam Vangala, Co-Founder & CEO, Reagene Biosciences, India

In Silico Screening of 8000 FDA Drugs for SARS-Cov-2 Antiviral Activity
Sreedhara R Voleti, Founder-MD/CEO, INDRAS Pvt. Ltd, India

3D Human Vascular Lung Model for Clinical Validation for Drug Repurposing as SARS-Cov-2 Antiviral Drugs
Uday Saxena, Co-Founder, Reagene Biosciences, India

Q/A Session

Open Discussion - (Expert - Dr Purushottam Dewang)

Networking in Forum Lounge

Closing Remarks and End of the meeting